345
Participants
Start Date
May 31, 2013
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
QAW039
QAW039 supplied as hard gelatin capsule in unit dose strength of 150 mg. Patient took 450 mg once daily (3 capsules taken with food in the morning) for the approximate period of the study (12 weeks)
Placebo QAW039
Matching placebo for QAW039 supplied as hard gelatin capsule were identical in appearance to their active counterparts. Patients took 3 QAW039 matching placebo capsules once a day ( taken with food in the morning) for the approximate period of the study (12 weeks)
Fluticasone 250 mcg
Fluticasone was supplied in inhalers with dose strength of 250 mcg. Patients took 250 mcg bid (morning and evening approximately 12 hours between doses) for a total dose of 500 mcg daily for the approximate period of the study (12 weeks).
Fluticasone 100 mcg
Background therapy - fluticasone was supplied in inhalers with dose strength of 100 mcg. All patients in the study other than the Atopic Fluticasone 150 mcg arm were given the 100 mcg dose strength inhalers and took fluticasone 100 mcg bid (taken morning and evening with approximately 12 hours between doses) as background therapy for the approximate period of the study (12 weeks).
Novartis Investigative Site, Liège
Novartis Investigative Site, Durban
Novartis Investigative Site, Erpent
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Gatesville
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Berlin
Novartis Investigative Site, Bucheon-si
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Charlotte
Novartis Investigative Site, Cheongju-si
Novartis Investigative Site, Charleston
Novartis Investigative Site, Sarasota
Novartis Investigative Site, Owensboro
Novartis Investigative Site, Cincinnati
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Witten
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, St Louis
Novartis Investigative Site, St Louis
Novartis Investigative Site, Wiesbaden
Novartis Investigative Site, Papillion
Novartis Investigative Site, Denver
Novartis Investigative Site, Denver
Novartis Investigative Site, Colorado Springs
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Rolling Hills Estates
Novartis Investigative Site, Encinitas
Novartis Investigative Site, San Diego
Novartis Investigative Site, Riverside
Novartis Investigative Site, Huntington Beach
Novartis Investigative Site, Mission Viejo
Novartis Investigative Site, Orange
Novartis Investigative Site, Palmdale
Novartis Investigative Site, San Jose
Novartis Investigative Site, Stockton
Novartis Investigative Site, Portland
Novartis Investigative Site, Seattle
Novartis Investigative Site, Craiova
Novartis Investigative Site, Craiova
Novartis Investigative Site, Timișoara
Novartis Investigative Site, Arad
Novartis Investigative Site, Deva
Novartis Investigative Site, Nagpur
Novartis Investigative Site, North Dartmouth
Novartis Investigative Site, Skillman
Novartis Investigative Site, Medford
Novartis Investigative Site, Lincoln
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Medellín
Novartis Investigative Site, Trutnov
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Karlovy Vary-Stara Rokle
Novartis Investigative Site, Teplice
Novartis Investigative Site, Marburg
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Panjim
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Coimbatore
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Lodz
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Gwangju
Novartis Investigative Site, Suwon
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY